In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study

This publication has 47 references indexed in Scilit:

• Antimicrobial Resistance of Streptococcus pneumoniae Isolates of Outpatients in Germany, 1999–2000
  Chemotherapy, 2004
• High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin
  Antimicrobial Agents and Chemotherapy, 2004
• Streptococcus pneumoniae and Streptococcus pyogenes isolated from a paediatric population in Great Britain and Ireland: the in vitro activity of telithromycin versus comparators
  Journal of Infection, 2004
• Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae
  Journal of Antimicrobial Chemotherapy, 2004
• CORRELATION BETWEEN BACTERIOLOGIC ERADICATION AND CLINICAL CURE IN ACUTE OTITIS MEDIA
  The Pediatric Infectious Disease Journal, 2004
• Emergence of Macrolide Resistance during Treatment of Pneumococcal Pneumonia
  New England Journal of Medicine, 2002
• Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries
  Antimicrobial Agents and Chemotherapy, 2002
• Sensitive and Specific Method for Rapid Identification of Streptococcus pneumoniae Using Real-Time Fluorescence PCR
  Journal of Clinical Microbiology, 2001
• The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands
  Clinical Microbiology & Infection, 2001
• Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
  Nucleic Acids Research, 1997